Anne CharlotteLe Floch Le Floch (Anne-Charlotte Le Floch)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Newly Diagnosed

Artificial Intelligence

Top Venues

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Anne CharlotteLe Floch Le Floch, Florence Orlanducci, Marie Christine Bene, Amira Ben Amara, Marie-Sarah Rouvière, Nassim Salem, Aude Le Roy, Charlotte Cordier, Clémence Demerlé, Samuel Granjeaud, Jean-François Hamel, Norbert Ifrah, Pascale Cornillet-Lefebvre, Jacques Delaunay, Christian Recher, Eric Delabesse, Arnaud Pigneux, Norbert Vey, Anne-Sophie Chretien, Daniel Olive
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia. Blood advances 8 (16) (2024)
Anne CharlotteLe Floch Le Floch, Florence Orlanducci, Marie Christine Bene, Amira Ben Amara, Marie-Sarah Rouvière, Nassim Salem, Aude Le Roy, Charlotte Cordier, Clémence Demerle, Samuel Granjeaud, Jean-François Hamel-Broza, Norbert Ifrah, Pascale Cornillet-Lefebvre, Jacques Delaunay, Christian Recher, Eric Delabesse, Arnaud Pigneux, Norbert Vey, Anne-Sophie Chretien, Daniel Olive
Low frequency of Vγ9Vδ2 T-cells predicts poor survival in newly diagnosed acute myeloid leukemia. Blood advances (2024)
Anne CharlotteLe Floch Le Floch, Florence Orlanducci, Marie Christine Bene, Amira Ben Amara, Marie-Sarah Rouvière, Nassim Salem, Aude Le Roy, Charlotte Cordier, Clémence Demerlé, Samuel Granjeaud, Jean-François Hamel, Norbert Ifrah, Pascale Cornillet-Lefebvre, Jacques Delaunay, Christian Recher, Eric Delabesse, Arnaud Pigneux, Norbert Vey, Anne-Sophie Chretien, Daniel Olive
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia. Blood advances 8 (16) (2024)
Anne CharlotteLe Floch Le Floch, Caroline Imbert, Nicolas Boucherit, Laurent Gorvel, Stéphane Fattori, Florence Orlanducci, Aude Le Roy, Lorenzo Archetti, Lydie Crescence, Laurence Panicot-Dubois, Christophe Dubois, Norbert Vey, Antoine Briantais, Amandine Anastasio, Carla Cano, Geoffrey C Guittard, Mathieu Frechin, Daniel Olive
Targeting BTN2A1 enhances Vγ9Vδ2 T-cell effector functions and triggers tumor cell pyroptosis. Cancer immunology research (2024)
Anne CharlotteLe Floch Le Floch, Marie-Sarah Rouvière, Nassim Salem, Amira Ben Amara, Florence Orlanducci, Norbert Vey, Laurent Gorvel, Anne-Sophie Chretien, Daniel Olive
Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells. Cells 12 (13) (2023)